Researchers track heart drug in tiniest patients
NCT ID NCT06613477
Summary
This study aims to learn how infants with a serious heart defect called single ventricle disease process the medication digoxin, which is already given to help their heart function. Researchers will collect small blood samples from up to 20 infants during their regular medical care to measure drug levels and related heart markers. The goal is to better understand the right dose for these vulnerable babies, but being in the study does not change their treatment plan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFANT, PREMATURE, DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke University Medical Center
RECRUITINGDurham, North Carolina, 27701, United States
Contact Email: •••••@•••••
-
Medical University of South Carolina
NOT_YET_RECRUITINGCharleston, South Carolina, 29425, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.